Efficacy rigor of neoadjuvant therapy: the role and synthesis of tumor subtype analysis. Letter to the Editor regarding ' Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial' by Conroy T et al

被引：0
|
作者：
Li, H. [1 ]
Gui, Y. [1 ]
Luo, Z. [1 ]
机构：
[1] North Sichuan Med Coll, Nanchong, Sichuan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷 / 11期
关键词：
D O I：
10.1016/j.annonc.2024.08.2333
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1064 / 1065
页数：2
相关论文
共 7 条
  • [1] Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial
    Moretto, R.
    Vetere, G.
    Di Maio, M.
    ANNALS OF ONCOLOGY, 2024, 35 (11) : 1063 - 1064
  • [2] Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial
    Conroy, T.
    Castan, F.
    Etienne, P. -l.
    Rio, E.
    Mesgouez-Nebout, N.
    Evesque, L.
    Vendrely, V.
    Artignan, X.
    Bouche, O.
    Gargot, D.
    Boige, V.
    Bonichon-Lamichhane, N.
    Louvet, C.
    Morand, C.
    de la Fouchardiere, C.
    Boileve, A.
    Delaye, M.
    Gourgou, S.
    Pezzella, V.
    Borg, C.
    ANNALS OF ONCOLOGY, 2024, 35 (10) : 873 - 881
  • [3] Advancing rectal cancer therapy: mFOLFIRINOX reduces metastasis and improves survival outcomes. Letter to the Editor regarding ' Total neoadjuvant therapy with mFOLFIRINOX versus preoperativechemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial' by Conroy T et al.
    Shubhra, Q. T. H.
    Cai, Q.
    ANNALS OF ONCOLOGY, 2024, 35 (11) : 1062 - 1063
  • [4] Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial.
    Conroy, Thierry
    Lamfichekh, Najib
    Etienne, Pierre-Luc
    Rio, Emmanuel
    Francois, Eric
    Mesgouez-Nebout, Nathalie
    Vandrely, Veronique
    Artignan, Xavier
    Bouche, Olivier
    Gargot, Dany
    Boige, Valerie
    Bonichon-Lamichhane, Nathalie
    Louvet, Christophe
    Morand, Clotilde
    De La Fouchardiere, Christelle
    Juzyna, Beata
    Rullier, Eric
    Marchal, Frederic
    Castan, Florence
    Borg, Christophe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial
    Conroy, Thierry
    Etienne, Pierre-Luc
    Rio, Emmanuel
    Evesque, Ludovic
    Mesgouez-Nebout, Nathalie
    Vendrely, Veronique
    Artignan, Xavier
    Bouche, Olivier
    Boileve, Alice
    Delaye, Matthieu
    Gargot, Dany
    Boige, Valerie
    Bonichon-Lamichhane, Nathalie
    Louvet, Christophe
    De La Fouchardiere, Christelle
    Morand, Clotilde
    Pezzella, Veronica
    Rullier, Eric
    Castan, Florence
    Borg, Christophe
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17)
  • [6] Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial.
    Conroy, Thierry
    Etienne, Pierre-Luc
    Rio, Emmanuel
    Evesque, Ludovic
    Mesgouez-Nebout, Nathalie
    Vendrely, Veronique
    Artignan, Xavier
    Bouche, Olivier
    Boileve, Alice
    Delaye, Matthieu
    Gargot, Dany
    Boige, Valerie
    Bonichon-Lamichhane, Nathalie
    Louvet, Christophe
    De La Fouchardiere, Christelle
    Morand, Clotilde
    Pezzella, Veronica
    Rullier, Eric
    Castan, Florence
    Borg, Christophe
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17_SUPPL) : LBA3504 - LBA3504
  • [7] Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial
    Fokas, Emmanouil
    Schlenska-Lange, Anke
    Polat, Buelent
    Klautke, Gunther
    Grabenbauer, Gerhard G.
    Fietkau, Rainer
    Kuhnt, Thomas
    Staib, Ludger
    Brunner, Thomas
    Grosu, Anca-Ligia
    Kirste, Simon
    Jacobasch, Lutz
    Allgaeuer, Michael
    Flentje, Michael
    Germer, Christoph-Thomas
    Gruetzmann, Robert
    Hildebrandt, Guido
    Schwarzbach, Matthias
    Bechstein, Wolf O.
    Suelberg, Heiko
    Friede, Tim
    Gaedcke, Jochen
    Ghadimi, Michael
    Hofheinz, Ralf-Dieter
    Roedel, Claus
    JAMA ONCOLOGY, 2022, 8 (01)
1